[Clinical Efficacy and Safety of Different Doses of Dexamethasone Combined with Bortezomib and Thalidomide for Treating Patients with Multiple Myeloma].

Li, Chang-Sheng; Ji, Ye; Zhang, Wan-Ping; Fu, Li-Ping

Li, Chang-Sheng; Ji, Ye; Zhang, Wan-Ping; Fu, Li-Ping.

Affiliation

Li CS; Second Ward of Oncology Department,Nanyang City Center Hospital, Nanyang 473009, Henan Province, China.
Ji Y; Second Department of Oncology,Nanyang City Center Hospital, Nanyang 473009, Henan Province, China.
Zhang WP; Department of Clinical Laboratorial Examination, Nanyang City Center Hospital, Nanyang 473009, Henan Province, China.
Fu LP; Medical Services Section, Nanyang City Center Hospital, Nanyang 473009, Henan Province, China. E-mail:lchshdoctor@2008.sina.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 26(3): 836-841, 2018 Jun.

Article de Zh | MEDLINE | ID: mdl-29950229

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple Type d'étude: Clinical_trials Limites: Humans Langue: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Sujet du journal: HEMATOLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google